Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Erasca, Inc. (ERAS) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Erasca, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1761918.
Total stock buying since 2021: $26,777,015.
Total stock sales since 2021: $3,753,000.
Total stock option exercises since 2021: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2024 | 80,000 | $181,920 | 0 | $0 | 0 | $0 |
2023 | 2,260,000 | $4,404,697 | 0 | $0 | 0 | $0 |
2022 | 377,692 | $2,328,798 | 0 | $0 | 0 | $0 |
2021 | 1,165,100 | $19,861,600 | 200,000 | $3,753,000 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2024-05 | 80,000 | $181,920 | 0 | $0 | 0 | $0 |
2023-12 | 1,040,000 | $1,764,458 | 0 | $0 | 0 | $0 |
2023-10 | 1,000,000 | $2,025,999 | 0 | $0 | 0 | $0 |
2023-06 | 100,000 | $275,000 | 0 | $0 | 0 | $0 |
2023-04 | 20,000 | $55,240 | 0 | $0 | 0 | $0 |
2023-03 | 100,000 | $284,000 | 0 | $0 | 0 | $0 |
2022-12 | 377,692 | $2,328,798 | 0 | $0 | 0 | $0 |
2021-08 | 200,000 | $4,420,000 | 0 | $0 | 0 | $0 |
2021-07 | 965,100 | $15,441,600 | 200,000 | $3,753,000 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2024-05-21 | Casdin Alexander W. (Director) | Buy | 80,000 | 2.27 | 181,920 |
2023-12-06 | Start Valerie Denise Harding (Director) | Buy | 10,000 | 1.85 | 18,480 |
2023-12-06 | Lim Jonathan E (Chairman & CEO) | Buy | 278,150 | 1.72 | 478,418 |
2023-12-05 | Lim Jonathan E (Chairman & CEO) | Buy | 721,850 | 1.69 | 1,217,760 |
2023-12-04 | Casdin Alexander W. (Director) | Buy | 30,000 | 1.66 | 49,800 |
2023-10-05 | Lim Jonathan E (Chairman & CEO) | Buy | 1,000,000 | 2.03 | 2,025,999 |
2023-06-08 | Lim Jonathan E (Chairman & CEO) | Buy | 100,000 | 2.75 | 275,000 |
2023-04-10 | Casdin Alexander W. (Director) | Buy | 20,000 | 2.76 | 55,240 |
2023-03-28 | Lim Jonathan E (Chairman & CEO) | Buy | 100,000 | 2.84 | 284,000 |
2022-12-21 | Bristol James Arthur (Director) | Buy | 20,000 | 4.14 | 82,800 |
2022-12-21 | Start Valerie Denise Harding (Director) | Buy | 10,000 | 4.64 | 46,400 |
2022-12-14 | Lim Jonathan E (Chairman & CEO) | Buy | 40,000 | 4.99 | 199,600 |
2022-12-13 | Cormorant Private Healthcare Fund Ii, Lp | Buy | 307,692 | 6.50 | 1,999,998 |
2021-08-10 | Chen Bihua | Buy | 200,000 | 22.10 | 4,420,000 |
2021-07-26 | Chen Bihua | Sale | 200,000 | 18.77 | 3,753,000 |
2021-07-20 | Cormorant Private Healthcare Fund Ii, Lp | Buy | 950,000 | 16.00 | 15,200,000 |
2021-07-20 | Start Valerie Denise Harding (Director) | Buy | 2,000 | 16.00 | 32,000 |
2021-07-20 | Multani Pratik S (Director) | Buy | 6,200 | 16.00 | 99,200 |
2021-07-20 | Hambleton Julie (Director) | Buy | 6,000 | 16.00 | 96,000 |
2021-07-20 | Garner Ebun (General Counsel) | Buy | 900 | 16.00 | 14,400 |
Insider trading activities including stock purchases, stock sales, and option exercises of ERAS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Erasca, Inc. (symbol ERAS, CIK number 1761918) see the Securities and Exchange Commission (SEC) website.